Atrium Flixene Grafts Recalled Due to Difficult-to-Remove Inner Tray Label
Atrium Medical Corporation is recalling Flixene Grafts because the inner tray label may adhere to the outer tray, making it difficult to remove the tray onto the sterile field.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a packaging/labeling issue that complicates the sterile setup process without explicit reports of patient injury or death.
Plain-English summary
Atrium Medical Corporation is recalling Flixene Grafts, which are intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access. The recall is due to a defect where the inner tray label may adhere to the wall of the outer tray, making it difficult to remove the tray onto the sterile field.
The affected products were manufactured between April 3, 2012, and May 14, 2013, and can be identified by their expiration dates, which range between April 2017 and May 2018. The recall covers products distributed worldwide, including the United States and numerous international locations.
Healthcare providers and facilities should stop using the affected Flixene Grafts and contact Atrium Medical Corporation for instructions on how to return the products.
The recalled product
- Product
- Flixene Grafts >or= 6mm Intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.
- Manufacturer
- Atrium Medical Corporation
- Category
- Medical Device — Vascular Grafts
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Product manufactured between April 3
- 2012 and May 14
- 2013 and can be identified by their expiration date
- between April 2017 and May 2018.
Distribution
Part of a larger recall action
This product is one of 14 recalled by Atrium Medical Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Atrium Medical Corporation
See all →- HighAtrium Medical Recalls Getinge PVC Thoracic Catheters Due to Endotoxin Testing
FDA (Devices) · 2026-09-16
- HighAtrium Medical Recalls Getinge PVC Thoracic Catheters Due to Endotoxin Testing
FDA (Devices) · 2026-09-16
- HighAtrium Medical Recalls Getinge PVC Thoracic Catheters Due to Endotoxin Testing
FDA (Devices) · 2026-09-16
- ModerateiCast Covered Stent Recalled for Unique Device Identifier Labeling Error
FDA (Devices) · 2024-10-16
- HighVascular graft component separation reported in Advanta VXT devices
FDA (Devices) · 2024-06-12
Same hazard · packaging defect
See all →- HighEmbosphere Microspheres Recalled Due to Packaging Sterility Concerns
FDA (Devices) · 2026-10-07
- ModerateAmneal Recalls Estradiol Gel Packets Due to Empty or Partially Full Containers
FDA (Drugs) · 2026-10-07
- HighCardinal Health Recalls Presource Convenience Kits Due to Seal Defects
FDA (Devices) · 2026-09-30
- ModerateAVID Medical Recalls Halyard IV Start Kits Due to Packaging Seal Issues
FDA (Devices) · 2026-09-30
- HighCardinal Health Recalls Presource Convenience Kits Due to Potential Seal Defects
FDA (Devices) · 2026-09-30
Similar recalls
- HighFLIXENE Vascular Graft Recall for Swivel Rod Component Separation
FDA (Devices) · 2024-06-12
- HighFLIXENE Vascular Graft Recalled for Slider Swivel Rod Separation
FDA (Devices) · 2024-06-12
- HighFLIXENE Vascular Graft Slider Rod Separation Defect Recall
FDA (Devices) · 2024-06-12
- HighVascular graft device recalled due to swivel rod separation
FDA (Devices) · 2024-06-12
- HighFLIXENE vascular graft recalled for slider separation defect
FDA (Devices) · 2024-06-12
- HighVascular Graft Component Separation Risk Triggers Worldwide Device Recall
FDA (Devices) · 2024-06-12